DB

Daniela Brunner

Chief Technology Officer

PsychoGenics

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
PsychoGenics
Industry
research
Employees
180.0
Seniority
C suite
Annual Revenue
8700000.0
Total Funding
3000000.0
Latest Funding
Other

Technologies

Outlook Sequence Monitor SPF Hubspot Campaign Monitor SuccessFactors (SAP) Remote AI

Keywords

animal models behavioral tests bioanalysis histology immunohistochemistry microdialysis molecular biology pharmacology electrophysiology eeg quality assurance research services cns research preclinical drug discovery behavioral testing neurodevelopmental disorders mental illness neurodegenerative disorders pain assessment biomarker analysis drug abuse liability eeg studies pharmacokinetics receptor occupancy cns disorders traumatic brain injury spinal cord injury ai platforms smartcube neurocube phenocube ex vivo testing cell therapies gene therapies psychotropic drugs neuropsychiatric evaluation translational research rodent models disease models anxiety studies depression studies schizophrenia autism spectrum disorder neurofilament biomarkers rare diseases epilepsy studies sleep disorders seizure disorders tailored studies novel therapeutics premedical capabilities high-throughput screening customized solutions quantitative histology behavioral assays therapeutic development clinical trials synthetic biology】.【}]} rare cns disorders health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans